IL6 and ovarian cancer: Of note, the increase in the expression of IL-6, another M2b marker [44] that can promote tumor growth and ascites formation in ovarian cancer [55,56], may explain the acceleration of ascites development in CpG-ODN/anti-PD-1 antibody-treated mice.